Literature DB >> 17113521

Post-traumatic and post-surgical Absidia corymbifera infection in a young, healthy man.

William H C Tiong1, T Ismael, J McCann.   

Abstract

Absidia corymbifera infection in a healthy individual is rare. Most of the infection occurs in immunocompromised patients or diabetic patients. Cutaneous and subcutaneous mucormycosis have been increasingly reported in the literature as a result of massive trauma with contaminated wounds. We present a case of cutaneous mucormycosis in a healthy, young patient after surgical amputation for a crush injury of the leg. We also highlight the importance of the high index of clinical suspicion in the diagnosis and treatment of this fungal infection in the hype of methicillin-resistant Staphylococcus aureus (MRSA) infection in hospital setting these days. Despite an initial life-saving amputation, it was inadequate to ensure the eradication of A. corymbifera infection. A second amputation was required with parenteral liposomal amphotericin B to achieve a satisfactory cure.

Entities:  

Mesh:

Year:  2006        PMID: 17113521     DOI: 10.1016/j.bjps.2006.03.053

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  4 in total

1.  A Unique Case of Intracranial Mucormycosis Following an Assault.

Authors:  Fadilah S Hussain; Namath S Hussain
Journal:  Cureus       Date:  2016-07-17

2.  The rise of an opportunistic infection called "Invasive Zygomycosis".

Authors:  Abdelkarim Waness; Ghuzayel Al Dawsari; Hamdan Al Jahdali
Journal:  J Glob Infect Dis       Date:  2009-07

3.  [Invasive mycoses and trauma].

Authors:  Alexandra Obradovic; Stefan Hajdu; Elisabeth Presterl
Journal:  Wien Med Wochenschr       Date:  2007

4.  Absidia Corymbifera in an immune competent accident victim with multiple abdominal injuries: case report.

Authors:  Rita Belfiori; Adelmo Terenzi; Laura Marchesini; Antonella Repetto
Journal:  BMC Infect Dis       Date:  2007-05-25       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.